Literature DB >> 29371436

Relationship Between Visceral Infarction and Ischemic Stroke Subtype.

Caitlin Finn1, Peter Hung1, Praneil Patel1, Ajay Gupta1, Hooman Kamel2.   

Abstract

BACKGROUND AND
PURPOSE: Most cryptogenic strokes are thought to have an embolic source. We sought to determine whether cryptogenic strokes are associated with visceral infarcts, which are usually embolic.
METHODS: Among patients prospectively enrolled in CAESAR (Cornell Acute Stroke Academic Registry), we selected those with a contrast-enhanced abdominal computed tomographic scan within 1 year of admission. Our exposure variable was adjudicated stroke subtype per the Trial of ORG 10172 in Acute Stroke Treatment classification. Our outcome was renal or splenic infarction as assessed by a single radiologist blinded to stroke subtype. We used Fisher exact test and multiple logistic regression to compare the prevalence of visceral infarcts among cardioembolic strokes, strokes of undetermined etiology, and noncardioembolic strokes (large- or small-vessel strokes).
RESULTS: Among 227 patients with ischemic stroke and a contrast-enhanced abdominal computed tomographic scan, 59 had a visceral infarct (35 renal and 27 splenic). The prevalence of visceral infarction was significantly different among cardioembolic strokes (34.2%; 95% confidence interval [CI], 23.7%-44.6%), strokes of undetermined etiology (23.9%; 95% CI, 15.0%-32.8%), and strokes from large-artery atherosclerosis or small-vessel occlusion (12.5%; 95% CI, 1.8%-23.2%; P=0.03). In multiple logistic regression models adjusted for demographics and vascular comorbidities, we found significant associations with visceral infarction for both cardioembolic stroke (odds ratio, 3.5; 95% CI, 1.2-9.9) and stroke of undetermined source (odds ratio, 3.3; 95% CI, 1.1-10.5) as compared with noncardioembolic stroke.
CONCLUSIONS: The prevalence of visceral infarction differed significantly across ischemic stroke subtypes. Cardioembolic and cryptogenic strokes were associated with a higher prevalence of visceral infarcts than noncardioembolic strokes.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; embolism; splenic infarction; stroke; tomography

Mesh:

Substances:

Year:  2018        PMID: 29371436      PMCID: PMC5828975          DOI: 10.1161/STROKEAHA.117.020035

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  IRMA study: Prevalence of subdiaphragmatic visceral infarction in ischemic stroke and atrial fibrillation.

Authors:  David Weisenburger-Lile; Delphine Lopez; Stephanie Russel; Jean-Emmanuel Kahn; Ana Veiga Hellmann; Antoine Scherrer; Nassima Ramdane; Adrien Wang; Serge Evrard; Jean-Pierre Decroix; Francois Mellot; Frederic Bourdain; Bertrand Lapergue
Journal:  Int J Stroke       Date:  2016-10-31       Impact factor: 5.266

2.  Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal stroke.

Authors:  Halim Abboud; Julien Labreuche; Fernando Gongora-Riverra; Arturo Jaramillo; Charles Duyckaerts; Philippe Gabriel Steg; Jean-Jacques Hauw; Pierre Amarenco
Journal:  Stroke       Date:  2007-03-22       Impact factor: 7.914

Review 3.  Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Authors:  Ryan Orgel; Daniel Wojdyla; David Huberman; Jonathan L Halperin; Günter Breithardt; Daniel E Singer; Keith A A Fox; Graeme J Hankey; Kenneth W Mahaffey; W Schuyler Jones; Manesh R Patel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-05

4.  Prevalence of subdiaphragmatic visceral infarction in cardioembolic stroke.

Authors:  T Slaoui; I F Klein; C Guidoux; L Cabrejo; E Meseguer; H Abboud; P C Lavalllée; M Mazighi; J Labreuche; P Amarenco
Journal:  Neurology       Date:  2010-03-03       Impact factor: 9.910

5.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

6.  Embolic strokes of undetermined source: the case for a new clinical construct.

Authors:  Robert G Hart; Hans-Christoph Diener; Shelagh B Coutts; J Donald Easton; Christopher B Granger; Martin J O'Donnell; Ralph L Sacco; Stuart J Connolly
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

  6 in total
  4 in total

1.  Relationship between Presence of Visceral Infarction and Functional Outcome among Patients with Acute Ischemic Stroke.

Authors:  Pirouz Piran; Yahya B Atalay; Ajay Gupta; Praneil Patel; Santosh B Murthy; Babak B Navi; Hooman Kamel; Alexander E Merkler
Journal:  Cerebrovasc Dis       Date:  2020-07-06       Impact factor: 2.762

2.  Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke.

Authors:  Setareh S Omran; Michael P Lerario; Gino Gialdini; Alexander E Merkler; Antonio Moya; Monica L Chen; Hooman Kamel; Maria DeSancho; Babak B Navi
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-12-27       Impact factor: 2.136

3.  Relationship between Lambl's excrescences and embolic strokes of undetermined source.

Authors:  Setareh Salehi Omran; Salama Chaker; Mackenzie P Lerario; Alexander E Merkler; Babak B Navi; Hooman Kamel
Journal:  Eur Stroke J       Date:  2020-01-21

Review 4.  Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.

Authors:  Danilo Toni; Alexander E Merkler; Manuela De Michele; Joshua Kahan; Irene Berto; Oscar G Schiavo; Marta Iacobucci
Journal:  Circ Res       Date:  2022-04-14       Impact factor: 23.213

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.